Ixiaro
Product Images NDC 42515-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ixiaro (NDC 42515-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Valneva Scotland Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

An instructional illustration labeled 'Figure 1' showing the preparation for administration of a 0.25 mL dose using a syringe. The diagram indicates positions to discard excess liquid and expel air to achieve the correct dose volume. No specific product labeling is visible beyond this preparation guidance.*

FDA Label Image

Figure2 (Figure2)

IXIARO Japanese Encephalitis Vaccine Inactivated, Adsorbed packaging label. The label includes product name, usage for intramuscular injection, and dosage information. It displays Valneva Scotland Ltd. as the manufacturer and Novartis Vaccines and Diagnostics, Inc. as the distributor. Storage instructions to refrigerate without freezing are noted. The label features barcodes and regulatory text.*

FDA Label Image

Figure3 (Figure3)

Label for IXIARO, Japanese Encephalitis Vaccine, showing NDC 42515-001-01, manufactured by Valneva Scotland Ltd. The label includes fields for lot number and expiration date, a barcode, and the text 'Rx only.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.